Company: MIRM
Filing Date: 2025-08-12
Form Type: S-3ASR
Source: 0001193125-25-178937
Chunk: 29

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-08-12
Form: S-3ASR
Chunk 29
---
 be purchased upon such exercise; |

22

| • |     | the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreements and 
 the warrants;                                                                                                    |

| • |     | the terms of any rights to redeem or call the warrants; |

| • |     | the terms of any rights to force the exercise of the warrants; |

| • |     | any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise 
 of the warrants;                                                                                                  |

| • |     | the dates on which the right to exercise the warrants will commence and expire; |

| • |     | the manner in which the warrant agreements and warrants may be modified; |

| • |     | a discussion of any material or special U.S. federal income tax consequences of holding or exercising the 
 warrants;                                                                                                 |

| • |     | the terms of the securities issuable upon exercise of the warrants; and |

| • |     | any other specific terms, preferences, rights or limitations of or restrictions on the warrants. |

Before exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including:

| • |     | in the case of warrants to purchase common stock, the right to receive dividends, if any, or, payments upon our 
 liquidation, dissolution or winding up or to exercise voting rights, if any;                                    |

| • |     | in the case of warrants to purchase preferred stock, the right to receive dividends, if any, or, payments upon 
 our liquidation, dissolution or winding up or to exercise voting rights, if any; or                            |

| • |     | in the case of warrants to purchase debt securities, the right to receive payments of principal of, or premium,            
 if any, or interest on, the debt securities purchasable upon exercise or to enforce covenants in the applicable indenture. |

Exercise of Warrants Each warrant will entitle the holder to purchase the securities that we specify in the applicable prospectus supplement at the exercise price that we describe in the applicable prospectus supplement. Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may exercise the warrants at any time up to the specified time on the expiration date that we set forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void. Unless we otherwise specify in the applicable prospect